Target intelligence / Profile preview

RBM12B divergent transcript (RBM12B-DT)

Target
RBM12B-DT
Molecular classification
Other
01

Overview

RBM12B divergent transcript (RBM12B-DT) refers to a transcript annotated near or overlapping the RNA binding motif protein 12B (**RBM12B**) gene, but does not correspond to a known protein-coding gene or established protein target. The "-DT" (divergent transcript) suffix is a nomenclature convention typically used in Ensembl and GENCODE transcript databases for non-coding or bidirectional transcripts that are found in genomic proximity to a coding gene, in this case, **RBM12B**. There is no evidence in publicly available biomedical databases or the peer-reviewed literature that RBM12B-DT encodes a protein, acts as a therapeutic target (such as a receptor, enzyme, transporter, or transcription factor), or is implicated in drug targeting or clinical biomarker research. The canonical gene **RBM12B** is an RNA-binding protein thought to be involved in RNA splicing[5], but RBM12B-DT itself is distinct from RBM12B and lacks detailed molecular or functional characterization. **Summary of findings:** - RBM12B-DT is not a well-defined molecular target. - It may be a non-coding RNA; there is no known protein product or functional data. - The entry is likely not suitable as a therapeutic target unless new data emerge. - If you are seeking information on the protein-coding gene *RBM12B* (RNA binding motif protein 12B), refer to that specifically; RBM12B is an RNA binding protein involved in RNA splicing, but RBM12B-DT is a distinct, poorly characterized transcript[5]. If your intent was to identify a targetable protein, RBM12B-DT does not fit this classification. You may want to clarify or directly reference the protein-coding RBM12B if that was the intended target.

Other names
RBM12B-DT

Beyond the preview

Go deeper on RBM12B divergent transcript (RBM12B-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RBM12B divergent transcript (RBM12B-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call